Skip to the main content.

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

Tom French : 28 July 2025

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.

Authors:

  • Tom French (Head of Process Technology- 3P innovation)
  • Dave Miller (CSO- AustinPx)
  • Derek Hennecke (CEO- Grand River Aseptic Manufacturing)

READ THE WHITEPAPER HERE
Interview with Founder Tom Bailey: Blister Dose Delivery Uniformity (DDU)

Interview with Founder Tom Bailey: Blister Dose Delivery Uniformity (DDU)

Georgia Lewis: 18 May 2026

Dose Delivery Uniformity (DDU) is one of the most persistent challenges in dry-powder inhaler development, and few have tackled it more directly...

Read More
How our robotic isolator technology is setting a new standard for aseptic fill-finish

How our robotic isolator technology is setting a new standard for aseptic fill-finish

David Johnson: 15 April 2026

In the world of pharmaceutical manufacturing, our robotic isolator technology sets a new standard for aseptic fill-finish technology. By integrating...

Read More
Key Factors to Consider During the Design Process in Aseptic Manufacturing

Key Factors to Consider During the Design Process in Aseptic Manufacturing

David Johnson: 13 April 2026

Demand for the design and development of specialist aseptic manufacturing solutions is being driven by the significant growth in biological drug...

Read More